Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.
Source:http://linkedlifedata.com/resource/pubmed/id/21211686
J. Am. Coll. Cardiol.
2011
Jan
11
57
2
153-9
